Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Electrolyte Disorders in Cancer Survivors | Causes, Symptoms, and Management

Share Button

Electrolyte Disorders in Cancer Survivors: An Overlooked Cause of Fatigue, Weakness, Neuropathy, and Heart Problems. Electrolyte disorders are common after cancer treatment. Learn which therapies cause low magnesium, sodium, potassium, calcium, and phosphate, and how survivors can protect their long-term health.

Electrolyte disorders in cancer patients and survivors are another wonderful example of my lament “I wish I knew then what I know now.” Fatigue, muscle cramping, muscle weakness, irregular heartbeat, etc. are a few of the common complaints made by cancer patients.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while damaging quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about electrolyte imbalances in cancer survivors.

Good luck,

David Emerson


Key Points

  • Cancer treatments frequently disrupt the body’s electrolyte balance.
  • Electrolyte abnormalities can persist for months or even years after therapy ends.
  • Survivors treated with cisplatin, carboplatin, oxaliplatin, EGFR inhibitors, stem cell transplantation, immunotherapy, and radiation are at increased risk.
  • Symptoms such as fatigue, muscle cramps, neuropathy, dizziness, irregular heartbeat, and “brain fog” may reflect electrolyte deficiencies rather than simply “normal recovery.”
  • Regular laboratory monitoring, nutrition, hydration, and correction of deficiencies can improve quality of life and reduce complications.


What Are Electrolytes?

Electrolytes are minerals dissolved in body fluids that carry electrical charges. They regulate:

  • Heart rhythm
  • Muscle contraction
  • Nerve function
  • Blood pressure
  • Hydration
  • Kidney function
  • Bone metabolism
  • Brain function

The major electrolytes include:

Electrolyte Primary Function
Sodium Fluid balance, nerve signaling
Potassium Heart rhythm, muscle contraction
Magnesium Energy production, nerve function, hundreds of enzyme reactions
Calcium Bones, muscles, nerves, blood clotting
Phosphorus Bone health, ATP energy production
Chloride Acid-base balance

Even small abnormalities can produce significant symptoms.


Why Cancer Survivors Are Especially Vulnerable

Many cancer survivors assume fatigue or weakness is simply part of survivorship. Sometimes it is—but electrolyte disorders are a common and treatable contributor.

Electrolyte problems may result from:

  • Chemotherapy-induced kidney injury
  • Radiation affecting endocrine glands or kidneys
  • Chronic diarrhea
  • Malabsorption
  • Poor nutrition
  • Vomiting
  • Long-term medications
  • Hormonal changes
  • Kidney damage
  • Endocrine dysfunction
  • Persistent inflammation

Recent reviews emphasize that electrolyte disorders are among the most common metabolic complications seen in oncology patients and may continue into survivorship.


Common Electrolyte Disorders After Cancer Treatment

1. Hypomagnesemia (Low Magnesium)

This is arguably the most overlooked electrolyte abnormality in oncology.

Common causes

  • Cisplatin
  • Carboplatin
  • Cetuximab
  • Panitumumab
  • HER2-targeted therapy
  • Chronic diarrhea
  • Proton pump inhibitors
  • Kidney injury

Magnesium deficiency can persist years after cisplatin therapy because of permanent kidney tubular damage.

Symptoms

  • Fatigue
  • Muscle cramps
  • Tremors
  • Neuropathy
  • Weakness
  • Irregular heartbeat
  • Anxiety
  • Insomnia

Why it matters

Low magnesium also makes it difficult to correct:

  • Low potassium
  • Low calcium

2. Hypokalemia (Low Potassium)

Low potassium often accompanies magnesium deficiency.

Causes

  • Vomiting
  • Diarrhea
  • Diuretics
  • Cisplatin
  • Poor intake
  • Kidney losses

Symptoms include:

  • Muscle weakness
  • Fatigue
  • Constipation
  • Palpitations
  • Dangerous heart rhythm abnormalities

Magnesium replacement is often necessary before potassium levels can normaliz


3. Hyponatremia (Low Sodium)

Hyponatremia is among the most common electrolyte disorders in cancer patients.

Possible causes include:

  • SIADH
  • Small-cell lung cancer
  • Vincristine
  • Cyclophosphamide
  • Pain medications
  • Antidepressants
  • Excess water intake
  • Adrenal insufficiency after immunotherapy

Symptoms range from mild to severe:

  • Confusion
  • Headache
  • Falls
  • Fatigue
  • Nausea
  • Memory problems
  • Seizures (in severe cases)

Hyponatremia is associated with poorer outcomes and often requires prompt medical evaluation.


4. Hypercalcemia

High calcium is usually associated with:

  • Bone metastases
  • Multiple myeloma
  • Parathyroid hormone-related peptide (PTHrP)

Symptoms include:

  • Constipation
  • Excessive thirst
  • Confusion
  • Kidney stones
  • Fatigue

Hypercalcemia is considered an oncologic emergency when severe.


5. Hypocalcemia

Low calcium may result from:

  • Vitamin D deficiency
  • Magnesium deficiency
  • Bisphosphonates
  • Denosumab
  • Kidney dysfunction

Symptoms include:

  • Muscle spasms
  • Tingling
  • Numbness
  • Hand cramping
  • Cardiac rhythm abnormalities

6. Phosphate Disorders

Low phosphate

Often occurs with:

  • Refeeding
  • Poor nutrition
  • Kidney losses
  • Certain targeted therapies

Symptoms include:

  • Severe fatigue
  • Muscle weakness
  • Bone pain
  • Difficulty breathing

High phosphate

Common in:

  • Tumor lysis syndrome
  • Kidney failure

Cancer Treatments Most Commonly Associated with Electrolyte Disorders

Therapy Common Electrolyte Problems
Cisplatin ↓ Magnesium, ↓ Potassium, ↓ Calcium
Carboplatin Magnesium loss
Oxaliplatin Magnesium loss
Cetuximab/Panitumumab Severe magnesium depletion
Stem cell transplant Multiple electrolyte abnormalities
Immunotherapy Sodium and potassium disorders via endocrine effects
Diuretics Potassium and magnesium loss
Radiation Endocrine dysfunction affecting sodium and calcium

Symptoms Survivors Should Never Ignore

Persistent symptoms may warrant electrolyte testing:

  • Muscle cramps
  • Muscle weakness
  • Fatigue
  • Heart palpitations
  • Tingling
  • Neuropathy
  • Dizziness
  • Confusion
  • Falls
  • Tremors
  • Difficulty walking
  • Brain fog

Can Nutrition Help?

Nutrition cannot always replace significant deficiencies, but it supports long-term recovery.

Magnesium-rich foods

  • Pumpkin seeds
  • Almonds
  • Cashews
  • Spinach
  • Black beans
  • Dark chocolate

Potassium-rich foods

  • Potatoes
  • Sweet potatoes
  • Avocados
  • Bananas
  • Yogurt
  • Beans

Calcium-rich foods

  • Dairy
  • Sardines
  • Tofu
  • Kale
  • Fortified plant milks

Phosphorus-rich foods

  • Fish
  • Poultry
  • Dairy
  • Lentils
  • Whole grains

Hydration is equally important, but survivors should avoid self-treating suspected electrolyte disorders with sports drinks or supplements without medical guidance, especially if they have kidney disease or heart failure.


Supplements: Helpful but Not Always Safe

Supplementation may be appropriate when laboratory testing confirms a deficiency, but dosing should be individualized.

For example:

  • Magnesium supplements can cause diarrhea.
  • Excess potassium may cause life-threatening heart rhythm disturbances.
  • Calcium supplements may increase kidney stone risk in susceptible individuals.
  • Phosphate replacement requires medical supervision.

Laboratory-guided treatment is safer than routine supplementation.


Questions to Ask Your Healthcare Team

  • Should my electrolytes be checked regularly?
  • Has my chemotherapy increased my long-term kidney risk?
  • Should magnesium be included in my blood work?
  • Could my fatigue be caused by electrolyte abnormalities?
  • Am I taking medications that worsen electrolyte loss?
  • Would meeting with an oncology dietitian be helpful?

Evidence-Based Bottom Line

Cancer survivorship is about more than detecting recurrence. Many long-term symptoms attributed to aging or “chemo recovery” may reflect correctable electrolyte disorders.

Fortunately, these abnormalities are often detectable with routine blood tests and can frequently be improved through appropriate treatment, nutritional counseling, medication adjustments, or targeted supplementation.

For survivors living with chronic fatigue, muscle weakness, neuropathy, or unexplained dizziness, discussing electrolyte evaluation with their oncology team may be an important step toward improving quality of life.


Research References

  1. Rashidi A, et al. Electrolyte Abnormalities in Cancer Patients. Kidney Blood Press Res. 2025. PubMed: https://pubmed.ncbi.nlm.nih.gov/39999798/
  2. Turcotte A, et al. Electrolyte Disturbances in Cancer Patients. Curr Opin Nephrol Hypertens. 2022. PubMed: https://pubmed.ncbi.nlm.nih.gov/35894276/
  3. Verzicco I, et al. Electrolyte Disorders Induced by Antineoplastic Drugs. Front Oncol. 2020. PubMed: https://pubmed.ncbi.nlm.nih.gov/32509580/
  4. Kuruppath J, Patel P. Hypomagnesemia and Hypokalemia: Considerations for Cancer Care. Clin J Oncol Nurs. 2022. PubMed: https://pubmed.ncbi.nlm.nih.gov/35604734/
  5. Rosner MH, Dalkin AC. Electrolyte Disorders Associated with Cancer. Adv Chronic Kidney Dis. 2014. PubMed: https://pubmed.ncbi.nlm.nih.gov/24359982/
  6. Hamroun A, et al. Electrolyte Disorders with Platinum-Based Chemotherapy. Cancer Chemother Pharmacol.2017. PubMed: https://pubmed.ncbi.nlm.nih.gov/28730291/
  7. Haveri KD, et al. Hypomagnesemia in the Cancer Patient. Kidney360. 2021. PubMed: https://pubmed.ncbi.nlm.nih.gov/35368816/

To learn more:

This article should serve as a supporting post within your Cancer Treatment Side Effects master hub and connect to several existing and planned resources:

Primary pillar pages

Related side-effect articles

Leave a Comment: